Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Epidemiologic, Descriptive and Cross-sectional Study of the IGF-1, IGFBP-3 and ALS Normative Ranges in a Healthy Paediatric Spanish Population, Divided Into Chronological Age, Sex and Pubertal Stage

NCT01676090 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01676090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01676090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Epidemiologic, Descriptive and Cross-sectional Study of the IGF-1, IGFBP-3 and ALS Normative Ranges in a Healthy Paediatric Spanish Population, Divided Into Chronological Age, Sex and Pubertal Stage
Lead sponsor
Ipsen
Phase
Observational
Overall status
Terminated
Start date
July 31, 2012
Completion date
October 31, 2013
Enrollment
304 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

igf-1 deficiency